Sort
23,748 grants matching “melanoma”
Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells
$514,430David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells
$514,429John H Sampson · Duke University · R01 · FY2015 · CA
6500 QTrap Mass Spectrometer for Yale University
$514,405Shrikant M Mane · Yale University · S10 · FY2014 · OD
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$514,346David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
$514,297Alejandro V Villagra · Georgetown University · R01 · FY2022 · CA
Lymphatic Mapping and Sentinel Node ANALYSIS
$514,263John Wayne Cancer Institute · R01 · FY2001 · CA
Role of metabolic crosstalk in determining immunity during tumor progression
$513,916Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2023 · CA
A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.
$513,904Pietro Ferrari · International Agency For Res On Cancer · R01 · FY2016 · AA
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
$513,840Chad A. Mirkin · Northwestern University · R01 · FY2025 · CA
Genetic Epidemiology
$513,753Alisa Goldstein · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Next Gen Virotherapy for GBM
$513,678Balveen Kaur · Augusta University · R01 · FY2024 · NS
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
$513,608Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
$513,608Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Tumor Microenvironment in Cancer Progression
$513,579Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
A High-Throughput Model for Human Melanoma
$513,524Sheri L. Holmen · Nevada Cancer Institute · R01 · FY2009 · CA
Defining the role of NF1 and SPRED1 loss in melanoma
$513,348Iwei Yeh · University Of California, San Francisco · R37 · FY2025 · CA
DKK2 regulates NK activation and tumor immunity
$513,312Dianqing Wu · Yale University · R01 · FY2021 · CA
DKK2 regulates NK activation and tumor immunity
$513,312Dianqing Wu · Yale University · R01 · FY2020 · CA
Proton-coupled folate/antifolate transport
$513,291Israel David Goldman · Albert Einstein College Of Medicine · R01 · FY2012 · CA
Development of Novel Preclinical Animal Models - CAPR Infrastructure
$513,288Shyam Sharan · Division Of Basic Sciences - Nci · ZIG · FY2017 · CA
Descriptive Studies and Record Linkage
$513,205Meredith Shiels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Drug-Loaded Nanobubbles for Ultrasound Enhanced Delivery to Colon Cancer Liver Metastasis
$513,175Agata A Exner · Case Western Reserve University · R01 · FY2019 · EB
Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapy
$513,119Lishan Su · University Of Maryland Baltimore · R01 · FY2023 · AI
Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapy
$513,119Lishan Su · University Of Maryland Baltimore · R01 · FY2022 · AI
Preserving CTLA-4 immune checkpoint for safer and more effective cancer immunotherapy
$513,119Lishan Su · University Of Maryland Baltimore · R01 · FY2021 · AI